🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the study is to investigate the efficacy, safety and toler...
Status
Completed
Location
1275.10.01019 Boehringer Ingelheim Investigational Site
Start Date
2013-01
Trial ID
NCT01778049
GIOIA represents a multicenter pragmatic prospective cohort study, aimed at...
Status
Completed
Location
Unit of Diabetes
Start Date
2018-01-15
Trial ID
NCT03918148
Three SGLT2i were commercially available in Italy at the time the trial was...
Status
Unknown
Location
Multiple Locations
Start Date
2021-06-30
Trial ID
NCT04796428
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
To investigate the pharmacokinetics of the test and the reference preparati...
Status
Completed
Location
The Affiliated Hospital of Qingdao University Phase I Clinical Research Center
Start Date
2022-07-01
Trial ID
NCT05956522
Treatments Being Tested
We will look for the possible effect of SGLT2i as a single agent to prevent...
Status
Unknown
Location
Multiple Locations
Start Date
2021-07-01
Trial ID
NCT04853615
Treatments Being Tested
In normal physiology, glucagon from pancreatic alpha cells plays an importa...
Status
Completed
Location
Center for Diabetes Research, Gentofte Hospital, Copenhagen University
Start Date
2016-05
Trial ID
NCT02792400
The efficacy and safety of a triple-pill combination therapy for advanced t...
Status
Recruiting
Location
Faisalabad clinics
Start Date
2025-10-30
Trial ID
NCT06862739
Treatments Being Tested
The primary objective of the current study is to investigate the relative b...
Status
Completed
Location
1275.3.1 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01189201
Treatments Being Tested
This trial compare the use of two different doses of Empagliflozin to place...
Status
Completed
Location
1275.9.01013 Boehringer Ingelheim Investigational Site
Start Date
2013-02-08
Trial ID
NCT01734785